Treace Medical Concepts
TMCI
71 hedge funds and large institutions have $407M invested in Treace Medical Concepts in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
25.43% more ownership
Funds ownership: 0% → 25.43% (+25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$56.4M |
| 2 |
PA
Perceptive Advisors
New York
|
+$39.3M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$31.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.4M |
| 5 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$24.5M |
Top Sellers
TMCI Hedge Fund Activity: Q2 2021 in Review
71 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2021, worth a combined $407M.
Buyers outnumbered sellers: 71 funds opened new TMCI positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AllianceBernstein, opening a new position worth an estimated $56.4M.
- 71 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $407M of Treace Medical Concepts stock for Q2 2021.
- 71 funds opened new Treace Medical Concepts positions in Q2 2021 and 0 closed out, a net change of +71 holders.
- The largest Treace Medical Concepts buyer in Q2 2021 was AllianceBernstein, an estimated $56.4M added.
Based on aggregated 13F filings for Q2 2021.